• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Forced Revision Can Still Inform-Lessons and Questions From the "Original" TWO Study.强制修订仍能提供信息——来自“原始”TWO研究的经验教训与问题
Transplantation. 2024 Nov 1;108(11):2164-2165. doi: 10.1097/TP.0000000000005064. Epub 2024 Jun 7.
2
Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.随机、双盲、安慰剂对照急性对照试验：右苯丙胺和哌甲酯缓释剂治疗青少年注意缺陷多动障碍。
CNS Drugs. 2017 Nov;31(11):999-1014. doi: 10.1007/s40263-017-0468-2.
3
Acetabular component liner exchange with highly crosslinked polyethylene for wear and osteolysis.髋臼部件衬垫更换与高交联聚乙烯磨损和骨溶解。
Bone Joint J. 2024 May 1;106-B(5 Supple B):59-65. doi: 10.1302/0301-620X.106B5.BJJ-2023-0821.R2.
4
One-stage Revision With Catheter Infusion of Intraarticular Antibiotics Successfully Treats Infected THA.关节内抗生素导管灌注一期翻修术成功治疗感染性全髋关节置换术
Clin Orthop Relat Res. 2017 Feb;475(2):419-429. doi: 10.1007/s11999-016-4977-y.
5
Lessons learned from COVID-19 vaccine acceptance among pregnant and lactating women from two districts in Kenya to inform demand generation efforts for future maternal RSV vaccines.从肯尼亚两个地区的孕妇和哺乳期妇女对 COVID-19 疫苗的接受情况中吸取的经验教训，为未来针对 RSV 的孕产妇疫苗的需求产生工作提供信息。
BMC Pregnancy Childbirth. 2024 Mar 27;24(1):221. doi: 10.1186/s12884-024-06425-y.
6
One-stage or two-stage revision surgery for prosthetic hip joint infection--the INFORM trial: a study protocol for a randomised controlled trial.人工髋关节感染的一期或二期翻修手术——INFORM试验：一项随机对照试验的研究方案
Trials. 2016 Feb 17;17:90. doi: 10.1186/s13063-016-1213-8.
7
Eighty-six Percent Failure Rate of a Modular-Neck Femoral Stem Design at 3 to 5 Years: Lessons Learned.86%的模块化颈部股骨柄设计在 3 至 5 年内失败：经验教训。
J Bone Joint Surg Am. 2016 Jun 15;98(12):e49. doi: 10.2106/JBJS.15.01082.
8
Revision strategy for malunited tibial plateau fracture caused by failure of initial treatment.初次治疗失败所致胫骨平台骨折畸形愈合的翻修策略
Acta Orthop Traumatol Turc. 2019 Nov;53(6):432-441. doi: 10.1016/j.aott.2019.08.018. Epub 2019 Sep 19.
9
Glycemic laboratory values are associated with increased length of stay and 90-day revision risk following surgical management of adult spinal deformity.血糖实验室值与成人脊柱畸形手术治疗后的住院时间延长及90天翻修风险相关。
Spine J. 2025 Mar;25(3):581-587. doi: 10.1016/j.spinee.2024.10.016. Epub 2024 Nov 4.
10
Learning lessons from the COVID-19 pandemic.从新冠疫情中吸取教训。
Health Econ Policy Law. 2023 Jan;18(1):88-103. doi: 10.1017/S1744133122000160. Epub 2022 Jul 27.

本文引用的文献

1
Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation.在阿仑单抗诱导后进行自体扩增调节性 T 细胞治疗的晚期治疗在活体供肾移植中是安全的，并有助于减少免疫抑制。
Transplantation. 2024 Nov 1;108(11):2278-2286. doi: 10.1097/TP.0000000000005065. Epub 2024 Oct 22.
2
Study Design: Human Leukocyte Antigen Class I Molecule A02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation.研究设计：肾移植中人类白细胞抗原I类分子A02嵌合抗原受体调节性T细胞
Kidney Int Rep. 2022 Apr 6;7(6):1258-1267. doi: 10.1016/j.ekir.2022.03.030. eCollection 2022 Jun.
3
Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients.无过度免疫抑制移植（TWO）研究方案：一项2b期随机对照单中心试验，旨在研究调节性T细胞疗法以促进活体供肾移植受者减少免疫抑制。
BMJ Open. 2022 Apr 15;12(4):e061864. doi: 10.1136/bmjopen-2022-061864.
4
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.肾移植中的调节性细胞治疗（ONE 研究）：七个非随机、单臂、1/2A 期的临床试验的协调设计和分析。
Lancet. 2020 May 23;395(10237):1627-1639. doi: 10.1016/S0140-6736(20)30167-7.
5
A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants.一项在活体供肾移植中使用体外扩增的受者调节性 T 细胞的 I 期临床试验。
Sci Rep. 2018 May 9;8(1):7428. doi: 10.1038/s41598-018-25574-7.

Forced Revision Can Still Inform-Lessons and Questions From the "Original" TWO Study.

作者信息

Maltzman Jonathan S

机构信息

Department of Medicine, Stanford University, Palo Alto, CA.

Geriatric Research and Education Clinical Center, Veterans Affairs (VA) Palo Alto Health Care System, Palo Alto, CA.

出版信息

Transplantation. 2024 Nov 1;108(11):2164-2165. doi: 10.1097/TP.0000000000005064. Epub 2024 Jun 7.

DOI:10.1097/TP.0000000000005064
PMID:38845093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11518647/
Abstract
摘要